We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,055 hedge funds and large institutions have $51.5B invested in Thermo Fisher Scientific in 2016 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 384 increasing their positions, 421 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 38

34% more call options, than puts

Call options by funds: $233M | Put options by funds: $174M

5% more capital invested

Capital invested by funds: $48.9B → $51.5B (+$2.6B)

3% more funds holding

Funds holding: 1,0241,055 (+31)

1% more funds holding in top 10

Funds holding in top 10: 7778 (+1)

9% less repeat investments, than reductions

Existing positions increased: 384 | Existing positions reduced: 421

2.57% less ownership

Funds ownership: 91.36%88.79% (-2.6%)

Holders
1,055
Holders Change
+31
Holders Change %
+3.03%
% of All Funds
28.15%
Holding in Top 10
78
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+1.3%
% of All Funds
2.08%
New
79
Increased
384
Reduced
421
Closed
38
Calls
$233M
Puts
$174M
Net Calls
+$59M
Net Calls Change
+$99.8M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
251
Cornerstone Capital
California
$15.8M -$973K -6,591 -6%
BWP
252
Baldwin Wealth Partners
Massachusetts
$15.6M +$180K +1,220 +1%
BSA
253
Braun Stacey Associates
New York
$15.6M +$1.38M +9,346 +10%
D.E. Shaw & Co
254
D.E. Shaw & Co
New York
$15.5M -$30.6M -207,453 -66%
AAM
255
Aureus Asset Management
Massachusetts
$15.4M +$646K +4,375 +4%
HNB
256
Huntington National Bank
Ohio
$15.4M -$7.34M -49,710 -32%
AC
257
Alexandria Capital
Virginia
$15.3M -$735K -4,980 -5%
SCM
258
Stevens Capital Management
Pennsylvania
$15.2M +$12.6M +85,371 +489%
PWAG
259
Polaris Wealth Advisory Group
California
$15.1M +$15.1M +102,271 New
EIM
260
ExxonMobil Investment Management
Texas
$15.1M +$794K +5,381 +6%
RSCM
261
Rock Springs Capital Management
Maryland
$14.8M
Bank of Nova Scotia
262
Bank of Nova Scotia
Ontario, Canada
$14.5M +$13.4M +90,480 +1,214%
HIMCH
263
Hartford Investment Management Co (HIMCO)
Connecticut
$14.4M -$116K -787 -0.8%
YIA
264
YHB Investment Advisors
Connecticut
$14.3M +$2.64M +17,920 +23%
CCM
265
Chilton Capital Management
Texas
$14.3M -$842K -5,704 -6%
CHA
266
Cedar Hill Associates
Illinois
$14.2M -$6.64M -45,020 -32%
TAM
267
Taurus Asset Management
New York
$14.2M -$10.3K -70 -0.1%
CCMH
268
Cornerstone Capital Management Holdings
New York
$14.2M -$793K -5,376 -5%
AC
269
Addenda Capital
Quebec, Canada
$14.1M -$4.58K -31 -0%
RJA
270
Raymond James & Associates
Florida
$14M +$758K +5,134 +6%
PP
271
Prudential plc
United Kingdom
$13.8M
LIM
272
Lathrop Investment Management
Arkansas
$13.8M +$60.5K +410 +0.4%
OC
273
Oppenheimer & Co
New York
$13.7M -$460K -3,117 -3%
EDRH
274
Edmond de Rothschild Holding
Switzerland
$13.5M -$1.11M -7,540 -8%
FAF
275
Fjarde Ap-fonden
Sweden
$13.5M -$6.2K -42 -0%

TMO Hedge Fund Activity: Q2 2016 in Review

1,055 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2016, worth a combined $51.5B — up 5.3% from $48.9B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new TMO positions and 38 closed out — a net gain of 41 holders — while 384 added to existing stakes and 421 trimmed.

The largest buyer was Sound Shore Management, adding an estimated $180M. The largest seller was Royal London Asset Management, cutting an estimated $2.01B.

  • 1,055 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2016, up from 1,024 in Q1 2016.
  • Funds reported $51.5B of Thermo Fisher Scientific stock for Q2 2016, up 5.3% quarter-over-quarter.
  • 79 funds opened new Thermo Fisher Scientific positions in Q2 2016 and 38 closed out, a net change of +41 holders.
  • The largest Thermo Fisher Scientific buyer in Q2 2016 was Sound Shore Management, an estimated $180M added.
  • The largest Thermo Fisher Scientific seller in Q2 2016 was Royal London Asset Management, an estimated $2.01B sold.

Based on aggregated 13F filings for Q2 2016.